Skip to main content
. 2007 Jun 26;97(2):210–217. doi: 10.1038/sj.bjc.6603857

Figure 3.

Figure 3

The average tumour volumes of mice bearing established tumours after treatment with three vaccines. A/J mice were engrafted with 106 unmodified Neuro-2A cells and vaccinated with Neuro-IL2/IL12 or AJ-IL2/IL12 cells or RPMI medium on days 3, 5 and 7 directly into the tumour. By 12 days post engraftment, mice vaccinated with Neuro-IL2/IL12 or AJ-IL2/IL12 (n=16 per group) had significantly smaller tumours compared to RPMI-treated controls (n=6). Day 12 is the point when all the control mice have to be killed due to their tumour size. Significance was determined by t-test (***P<0.001).